RMD
Income statement / Annual
Last year (2025), ResMed Inc.'s total revenue was $5.15 B,
an increase of 9.84% from the previous year.
In 2025, ResMed Inc.'s net income was $1.40 B.
See ResMed Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$5.15 B |
$4.69 B |
$4.22 B |
$3.58 B |
$3.20 B |
$2.96 B |
$2.61 B |
$2.34 B |
$2.07 B |
$1.84 B |
| Cost of Revenue |
$2.09 B
|
$2.03 B
|
$1.87 B
|
$1.55 B
|
$1.36 B
|
$1.24 B
|
$1.07 B
|
$978.03 M
|
$864.99 M
|
$772.22 M
|
| Gross Profit |
$3.05 B
|
$2.66 B
|
$2.36 B
|
$2.02 B
|
$1.84 B
|
$1.72 B
|
$1.54 B
|
$1.36 B
|
$1.20 B
|
$1.07 B
|
| Gross Profit Ratio |
0.59
|
0.57
|
0.56
|
0.57
|
0.58
|
0.58
|
0.59
|
0.58
|
0.58
|
0.58
|
| Research and Development Expenses |
$331.28 M
|
$307.53 M
|
$287.64 M
|
$253.58 M
|
$225.28 M
|
$201.95 M
|
$180.65 M
|
$155.15 M
|
$144.47 M
|
$118.65 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$600.37 M
|
$553.97 M
|
$488.06 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$991.02 M
|
$917.14 M
|
$874.00 M
|
$739.37 M
|
$670.39 M
|
$676.69 M
|
$645.01 M
|
$600.37 M
|
$553.97 M
|
$488.06 M
|
| Other Expenses |
$47.30 M
|
$110.75 M
|
$62.15 M
|
$31.08 M
|
$39.75 M
|
$30.09 M
|
$131.66 M
|
$64.82 M
|
$77.51 M
|
$30.84 M
|
| Operating Expenses |
$1.37 B
|
$1.34 B
|
$1.22 B
|
$1.02 B
|
$935.42 M
|
$908.73 M
|
$957.32 M
|
$820.33 M
|
$775.95 M
|
$637.55 M
|
| Cost And Expenses |
$3.46 B
|
$3.37 B
|
$3.09 B
|
$2.58 B
|
$2.29 B
|
$2.15 B
|
$2.03 B
|
$1.80 B
|
$1.64 B
|
$1.41 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$362.00 K
|
$1.02 M
|
$2.30 M
|
$16.38 M
|
$17.09 M
|
$16.86 M
|
| Interest Expense |
$12.61 M
|
$45.71 M
|
$47.38 M
|
$22.31 M
|
$23.99 M
|
$40.38 M
|
$36.16 M
|
$28.36 M
|
$28.24 M
|
$11.21 M
|
| Depreciation & Amortization |
$235.81 M
|
$216.21 M
|
$196.52 M
|
$193.84 M
|
$191.52 M
|
$181.37 M
|
$150.80 M
|
$119.96 M
|
$112.16 M
|
$86.85 M
|
| EBITDA |
$1.91 B |
$1.53 B |
$1.36 B |
$1.18 B |
$1.10 B |
$990.43 M |
$705.80 M |
$680.22 M |
$568.89 M |
$522.72 M |
| EBITDA Ratio |
0.37
|
0.33
|
0.32
|
0.33
|
0.35
|
0.33
|
0.27
|
0.29
|
0.28
|
0.28
|
| Operating Income Ratio |
0.33
|
0.28
|
0.27
|
0.28
|
0.28
|
0.27
|
0.22
|
0.23
|
0.21
|
0.23
|
| Total Other Income/Expenses Net |
-$7.80 M
|
-$55.10 M
|
-$30.21 M
|
-$39.80 M
|
-$20.02 M
|
-$76.57 M
|
-$60.42 M
|
-$20.52 M
|
-$7.06 M
|
$10.61 M
|
| Income Before Tax |
$1.68 B
|
$1.26 B
|
$1.10 B
|
$960.48 M
|
$883.66 M
|
$733.09 M
|
$518.85 M
|
$521.31 M
|
$418.74 M
|
$439.57 M
|
| Income Before Tax Ratio |
0.33
|
0.27
|
0.26
|
0.27
|
0.28
|
0.25
|
0.2
|
0.22
|
0.2
|
0.24
|
| Income Tax Expense |
$276.84 M
|
$243.85 M
|
$204.11 M
|
$181.05 M
|
$409.16 M
|
$111.41 M
|
$114.26 M
|
$205.72 M
|
$76.46 M
|
$87.16 M
|
| Net Income |
$1.40 B
|
$1.02 B
|
$897.56 M
|
$779.44 M
|
$474.51 M
|
$621.67 M
|
$404.59 M
|
$315.59 M
|
$342.28 M
|
$352.41 M
|
| Net Income Ratio |
0.27
|
0.22
|
0.21
|
0.22
|
0.15
|
0.21
|
0.16
|
0.13
|
0.17
|
0.19
|
| EPS |
9.55 |
6.94 |
6.12 |
5.34 |
3.27 |
4.31 |
2.83 |
2.21 |
2.42 |
2.51 |
| EPS Diluted |
9.51 |
6.92 |
6.09 |
5.3 |
3.24 |
4.27 |
2.8 |
2.19 |
2.4 |
2.49 |
| Weighted Average Shares Out |
$146.72 M
|
$147.02 M
|
$146.77 M
|
$146.07 M
|
$145.31 M
|
$144.34 M
|
$143.11 M
|
$142.76 M
|
$141.36 M
|
$140.24 M
|
| Weighted Average Shares Out Diluted |
$147.34 M
|
$147.55 M
|
$147.46 M
|
$147.04 M
|
$146.45 M
|
$145.65 M
|
$144.48 M
|
$143.99 M
|
$142.45 M
|
$141.67 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
